An introduction to inverse probability of treatment weighting in observational research
Nicholas C Chesnaye(Amsterdam Neuroscience), Kitty J. Jager(Amsterdam University Medical Centers), Edouard L. Fu(Leiden University Medical Center), Giovanni Tripepi(National Research Council), Carmine Zoccali(Biogem), Vianda S Stel(Amsterdam UMC Location University of Amsterdam), Friedo W. Dekker(Leiden University Medical Center)
Cited by 877
Related Papers
Obesity and Kidney Disease: Hidden Consequences of the Epidemic
|American Journal of Nephrology|2017|2.2k
Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study
|The Lancet|2001|1.1k
Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria
|The Lancet|1999|909
A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases
|Kidney International|2019|886
External validation of prognostic models: what, why, how, when and where?
|Clinical Kidney Journal|2020|808